drugset / Trial / NCT01127256

Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation

NCT01127256

Phase 4 Completed 200 enrolled Eisai Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy and safety of zonisamide with carbamazepine and to determine the optimum dose of zonisamide in patients with epilepsy.

Timeline

Start
2006-05-31
Primary completion
2009-05-31
Completion
2009-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbamazepine Small molecule 1200 mg
Subject Zonisamide Other / unclassified 600 mg

Indications